Manager, Commercial Strategy Analytics

MFS Investments; Boston (MA); Hybrid; USD 127,000 - 167,000; Full time

Job summary

Entrada Therapeutics is seeking a business strategy professional to synthesize competitive insights and lead market research for its pre-commercial and commercial readiness efforts from its Boston headquarters. The role emphasizes data-driven analyses, forecasting, and collaboration across leadership to shape strategy and decisions.

You will work in a hybrid setup, engaging with senior leaders and external experts while building financial models and communicating findings to inform

Qualifications

• Bachelor’s degree in a life sciences discipline required; PhD, MBA or other advanced degree strongly preferred.
• 5+ years of relevant analytical experience in market research, equity research, life sciences consulting, or biotech.
• Direct experience synthesizing and communicating competitive insights from drug development programs.
• Excellent analytical and communication skills to engage external experts and internal stakeholders.

Responsibilities

• Support asset-level and portfolio-level pre-commercial or commercial readiness analyses across indications and geographies.
• Conduct market sizing, epidemiology, competitive landscape, and pricing & reimbursement analyses.
• Build and maintain revenue forecast models incorporating evolving clinical, regulatory, and market insights.
• Support ongoing initiatives across the corporate strategy team.
• Capture market data to generate insights and communicate findings efficiently.

Skills

Analytical skills

Strategic thinking

Communication skills

Team collaboration

Education

Bachelor’s degree in life sciences

PhD or MBA or advanced degree preferred

Job description

The Organization

What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1).

2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670).

We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.

The Perfect Addition to Our Team

You are interested in working at the intersection of life sciences and business. You want to join a high-growth biotech company in a business strategy role to support the team by synthesizing and communicating strategic insights as we prepare for commercial launch. You bring to the table a combination of an inquisitive spirit, critical thinking, and deep analytical skills and you love performing data-driven analyses to generate strategic insights. You are comfortable working in ambiguity and thrive in fast paced situations. You look forward to working with and learning from leaders across the organization in a high impact role.

The Opportunity

This position will report to the Director of Business Development and Corporate Strategy and support a variety of projects for the early commercial strategy team. Example workstreams include partnership and ownership across competitive intelligence, market research, and forecasting analysis. You’ll conduct primary and secondary market research to gather data to drive key insights and analyses to support Entrada’s pre-commercial strategy. You’ll be expected to be a key member of the team by distilling market insights and data in a timely fashion to generate strategic takeaways and recommendations for key decision makers across the organization.

Responsibilities

• Support development of asset-level and portfolio-level pre-commercial or commercial readiness analyses across target indications and geographies.
• Conduct market sizing, epidemiology, competitive landscape, and pricing & reimbursement analyses.
• Build and maintain revenue forecast models incorporating insights from the evolving clinical, regulatory, and market landscape.
• Support continued development of existing initiatives across the corporate strategy team.
• Gather and capture market data to support data-driven analyses, generate strategic insights, and communicate findings in an efficient manner.

The Necessities

At Entrada, our passion for science, our devotion to patients and our values drives our behavior:

• Humanity - We genuinely care about patients and about one another.
• Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
• Creativity - We are creative problem solvers.
• Collaboration - We are more than the sum of our parts.
• Curiosity - We have a growth mindset and push conventional thought and theory.

To thrive on our team, you will need to come with:

• Bachelor’s degree in a life sciences discipline required; PhD, MBA or other advanced degree strongly preferred.
• 5+ years of relevant experience, preferably in an analytical role such as market research, equity research, life sciences consulting, commercial analytics, or prior experience in biotech/pharma.
• Direct experience synthesizing and communicating competitive insights from drug development programs and/or companies.
• Exceptional analytical skills combined with a broad understanding of the life sciences business and R&D process.
• Excellent communication skills engaging with external experts and internal stakeholders to gather insights and feedback.
• Experience building and interpreting financial models and communicating modeling outputs to support strategic decision making.
• Familiarity with the rare disease space and a desire to work in a fast-paced, innovative, and collaborative environment.
• Ability to be a team player with a can-do attitude and a willingness to embrace new challenges and the flexibility to adjust course, based on new findings and team inputs.

This is a hybrid position, with the requirement for candidates to be based out of Entrada Therapeutics headquarters office 2-3 days per week in Boston, MA.

What We Offer: Meaningful Work, Fair Rewards, and Real Support

At Entrada Therapeutics, we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position, along with insight into our compensation philosophy, in accordance with certain state requirements in the United States and fostering a fair and open environment at the onset.

But we also know it is more than just pay. When you join Entrada, you’ll be part of a mission-driven team with access to comprehensive health, dental and vision coverage; life and disability insurance; with a 401(k) match. We pride ourselves on offering competitive benefits that empower our employees and reflect the value of their contributions – offering paid, gender-inclusive parental leave, holistic support for your health and well-being, education reimbursement, discretionary time off and commuting benefits aligned to your working model. If you find yourself working from our office in Boston’s Seaport District, this puts you steps away from some of the best the city has to offer.

At Entrada, our approach to compensation is grounded in transparency, equity, and performance, recognizing the unique contributions each person brings. We believe meaningful work deserves meaningful reward, and view compensation as one way to show appreciation for the collaboration, curiosity, and commitment that drive our mission forward.

The salary for this opportunity ranges from $126,800 - $166,500. The final base compensation offered will depend on several considerations which include but may not be limited to a candidate’s skills, competencies, experience and other job-related factors permitted by law. The final salary offered may fall outside of this range. #LI-Hybrid #LI-JF1

Equal Opportunity Employer

Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.

Third Party Staffing Agencies

Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.

Privacy Statement

Entrada Therapeutics, Inc. (the “Entrada, “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.